
GC73714
PARG-IN-4
Also known as 1-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-4-[(3S,5S)-3,5-dimethylpiperazin-1-yl]-N-(1-methylcyclopropyl)indazole-6-sulfonamide
PARG-IN-4 (Formula (A)) is an orally active and cell-permeable PARG inhibitor
ChemicalCAS2988890-20-4MW497.59FormulaC20H25F2N7O2S2
- CAS number
- 2988890-20-4
- Molecular weight
- 497.59
- Formula
- C20H25F2N7O2S2
- Solubility
- DMSO : 20 mg/mL (40·19 mM; ultrasonic and warming and heat to 80°C)
- InChIKey
- AQOUTSJIZZVANZ-RYUDHWBXSA-N
- Catalogue number
- GC73714
- Brand
- GLPBIO
Computed properties PubChem CID 169078314 · XLogP 2.7 · TPSA 142 Ų · H-bond donors 2
- XLogP
- 2.7
- TPSA
- 142 Ų
- H-bond donors
- 2
- H-bond acceptors
- 11
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES C[C@H]1CN(C[C@@H](N1)C)C2=CC(=CC3=C2C=NN3C4=NN=C(S4)C(F)F)S(=O)(=O)NC5(CC5)C
Computed descriptors from PubChem (CID 169078314), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il